ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Poly(ADP-ribose) Polymerase 1 (PARP1) in Atherosclerosis: From Molecular Mechanisms to Therapeutic Implications

Xu Suowen*; Bai Peter; Little Peter J; Liu Peiqing
Medicinal Research Reviews2014-5DOI: 10.1002/med.21300
8被引7阅读
引用收藏
分享

摘要

Poly(ADP-ribosyl)ation reactions, carried out by poly(ADP-ribose) polymerases (PARPs/ARTDs), are reversible posttranslational modifications impacting on numerous cellular processes (e.g., DNA repair, transcription, metabolism, or immune functions). PARP1 (EC 2.4.2.30), the founding member of PARPs, is particularly important for drug development for its role in DNA repair, cell death, and transcription of proinflammatory genes. Recent studies have established a novel concept that PARP1 is critically involved in the formation and destabilization of atherosclerotic plaques in experimental animal models and in humans. Reduction of PARP1 activity by pharmacological or molecular approaches attenuates atherosclerotic plaque development and enhances plaque stability as well as promotes the regression of pre-established atherosclerotic plaques. Mechanistically, PARP1 inhibition significantly reduces monocyte differentiation, macrophage recruitment, Sirtuin 1 (SIRT1) inactivation, endothelial dysfunction, neointima formation, foam cell death, and inflammatory responses within plaques, all of which are central to the pathogenesis of atherosclerosis. This article presents an overview of the multiple roles and underlying mechanisms of PARP1 activation (poly(ADP-ribose) accumulation) in atherosclerosis and emphasizes the therapeutic potential of PARP1 inhibition in preventing or reversing atherosclerosis and its cardiovascular clinical sequalae.

学科与关键词

关键词
reviewADP ribosylationPARPSIRT1atherosclerosis
相关
加载中…
  • LOX-1 in atherosclerosis: biological functions and pharmacological modifiers
    Xu Suowen*; Ogura Sayoko; Chen Jiawei; Little Peter J; Moss Joel; Liu PeiqingCellular and Molecular Life Sciences, 2013, 70(16): 2859-2872.被引 31
  • Macrophage polarization states in atherosclerosis
    Wu, Jiayong; He, Shengping; Song, Zhengkun; Chen, Sikai; Lin, Xuefeng; Sun, Huimei; Zhou, Pengyu; Peng, Qinbao; Du, Songlin; Zheng, Shaoyi*; Liu, Xiu*Frontiers in Immunology, 2023, 14: 1185587.被引 4
  • The Molecular Pathways of Pyroptosis in Atherosclerosis
    Song, Dan; Li, Manman; Yu, Xue; Wang, Yuqin; Fan, Jiaying; Yang, Wei; Yang, Liming*; Li, Hong*Frontiers in Cell and Developmental Biology, 2022, 10: 824165.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Medicinal Research Reviews
发表日期
2014-05
卷期
第 34 卷, 第 3 期
页码
644-675
DOI
10.1002/med.21300
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q1
成果收录
SCI
资助标注
National Natural Science Foundation of China [81072641, 81273499]; National Science and Technology Major Project of China [2011ZX09401-307]; Team Item of Natural Science Foundation of Guangdong Province [S2011030003190]; Major Project of Guangdong Province [2008A030201013, 2012A080201007]; Major Project of Department of Education of Guangdong Province [CXZD1006]

作者

  • X

    Xu Suowen (通讯) (第一作者)

  • B

    Bai Peter

查看全部 4 位作者收起作者
  • L

    Little Peter J

  • L

    Liu Peiqing

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417